About dianova
dianova is a company based in Hamburg (Germany) founded in 1982 was acquired by Calibre Scientific in February 2020. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. The company has 38 employees. dianova offers products and services including Secondary Antibodies and Primary Antibodies. dianova operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
- Headquarter Hamburg, Germany
- Employees 38
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dianova.com
- Acquired by Calibre Scientific (Feb 2020)
- Legal Name Biozol
- Investors
- Employee Count38
- Acquired byCalibre Scientific
(Feb 2020)
Products & Services of dianova
dianova offers a comprehensive portfolio of products and services, including Secondary Antibodies and Primary Antibodies.
Secondary antibodies are provided for immunohistochemical detection purposes.
Primary antibodies are offered for research and diagnostics.
Investors in dianova
dianova has secured backing from 1 investor. Prominent investors backing the company include Calibre Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of contract based research, manufacturing, distribution and other services for biopharma sector | 2016 | calibrescientific.com | Los Angeles, United States |
Investor details for dianova
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of dianova
2 dated milestones of dianova across 38 years, from founding to its latest funding, stage changes and deals.
- Founded dianova is founded.
- Exit Acquired by Calibre Scientific.
Competitors of dianova
dianova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research | |
| seracare.com | 1984 | Milford, United States | – | – | Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability |
Detailed competitors of dianova
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of dianova
The website of dianova (dianova.com) receives about 6.5K visits a month.
- Monthly visits6.5K
▲ 11.5% vs previous month
Websites whose visitors overlap most with dianova. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| azurebiosystems.com | 100% | 34.5K | #971,267 | View details | |
| antibodies-online.com | 99% | 57.4K | #648,443 | View details | |
| jacksonimmuno.com | 97% | – | #680,486 | View details | |
| norgenbiotek.com | 90% | 32.2K | #969,538 | View details | |
mrcgene.com | mrcgene.com | 90% | – | #5,514,255 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for dianova
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to dianova
10 companies that operate in the same segment as dianova (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about dianova
dianova was founded in 1982.
dianova is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
dianova has 38 employees.
dianova is involved in the distribution of high-quality secondary and primary antibodies for immunohistochemistry and other life science products. The company serves customers in research and routine diagnostics since 1982. It offers a wide range of over 9000 secondary antibodies, representing the largest selection in Europe, sourced from renowned manufacturers like Jackson ImmunoResearch, Southern Biotech, and Vector Laboratories. Additionally, over 1500 secondary antibodies are marketed under the dianova brand. The company, now part of BIOZOL since late 2020, focuses on sectors such as neuropathology, immuno-oncology, and general pathology with innovative solutions for tissue detection and tumor immunology.
dianova's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
dianova offers Secondary Antibodies and Primary Antibodies.
dianova has 1 investor. Key investors include Calibre Scientific.
dianova operates through Biozol.
Yes. dianova was acquired by Calibre Scientific in February 2020.